Nathan Feiertag
Overview
Explore the profile of Nathan Feiertag including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
29
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feiertag N, Tawfik M, Loloi J, Patel R, Green B, Zhu M, et al.
Urology
. 2023 Mar;
176:7-15.
PMID: 36963667
Objective: To perform a systematic review of the literature on plant-based and plant-forward diets and the prevention/treatment of the following common men's health conditions: prostate cancer (PCa), erectile dysfunction (ED),...
2.
Abramson M, Feiertag N, Javidi D, Babar M, Loeb S, Watts K
BJUI Compass
. 2023 Feb;
4(2):206-213.
PMID: 36816146
Objectives: This study aimed to evaluate content quality and racial/ethnic representation, particularly of high-risk cohorts, of prostate cancer screening videos on YouTube (YT) and TikTok (TK). Materials And Methods: The...
3.
Feiertag N, Barry E, Abramson M, Park J, Kovac E, Aboumohamed A, et al.
Clin Genitourin Cancer
. 2023 Jan;
21(2):258-264.
PMID: 36621462
Introduction: The use of urine cytology in the surveillance of non-muscle invasive bladder cancer (NMIBC) is widely variable in clinical practice. We studied the impact of surveillance urine cytology on...
4.
Gupta K, Feiertag N, Jacobs D, Abramson M, Alaimo A, Harris A, et al.
Urology
. 2022 Dec;
173:81-86.
PMID: 36572224
Objective: To design and implement a simple electronic medical record-based ureteral stent tracker. To assess its impact on stent dwell time and stent-related complications. Methods: Patients with stents placed 12...
5.
DeMasi M, Segall M, Mengotto A, Cuartas P, Feiertag N, Loloi J, et al.
World J Urol
. 2022 Nov;
40(12):3061-3066.
PMID: 36371742
Introduction: Opioids are often used to manage postoperative pain. Non-narcotic alternatives have increasingly been used to reduce opioid usage. We conducted an open-label randomized non-inferiority clinical trial to compare non-opioid...
6.
Gupta K, Feiertag N, Gottlieb J, Kase J, Zhu D, Green B, et al.
Urology
. 2022 Oct;
171:49-56.
PMID: 36265551
Objective: To evaluate practice patterns of post-ureteroscopy (URS) imaging, to assess predictors of imaging order, type and completion, and to analyze impact on patient management. Methods: We conducted a retrospective...
7.
Green B, Labagnara K, Feiertag N, Gupta K, Donnelly J, Watts K, et al.
Urology
. 2022 Oct;
170:46-52.
PMID: 36183747
Objective: To investigate the financial toxicity (FT) related to kidney stone treatment. Methods: We performed a cross-sectional cohort study with multi-institutional in-person and online cohorts of stone formers. Participants were...
8.
Green B, Labagnara K, MacDonald E, Feiertag N, Zhu M, Gupta K, et al.
World J Urol
. 2022 Sep;
40(11):2641-2647.
PMID: 36125503
Purpose: This study aimed to investigate the relationship between self-reported food security and kidney stone formation. Methods: Data were collected from the National Health and Nutrition Examination Survey (NHANES), a...
9.
Patel R, Dave P, Loloi J, Freeman S, Feiertag N, Babar M, et al.
Urology
. 2022 Aug;
169:256-266.
PMID: 35952806
Objective: To study implicit and explicit gender biases in YouTube videos describing common urologic conditions based on language patterns, speaker gender, and speaker profession. Methods: Using a Boolean search, the...
10.
Green B, Feiertag N, Watts K, Small A
Urolithiasis
. 2022 Jun;
50(4):447-453.
PMID: 35689693
Our goal was to assess the use and perceptions of complementary and alternative medicine (CAM) for kidney stones among a diverse, urban population. This was a cross-sectional study of patients...